Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
08 August 2007Website:
http://www.masimo.comNext earnings report:
27 February 2025Last dividends:
23 November 2012Next dividends:
N/APrice
after hours | Tue, 19 Nov 2024 23:04:11 GMTDividend
Analysts recommendations
Institutional Ownership
MASI Latest News
MAMO sees a 30.7% increase in non-GAAP operating income in Q3 2024. Healthcare segment revenues increase 11.5%, driving overall growth amid strategic shifts.
Although the revenue and EPS for Masimo (MASI) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Apple convinced a federal jury on Friday that health monitoring tech company Masimo's smartwatches infringe two of its design patents.
Masimo (MASI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI), a leading global medical innovator, today announced the appointments of Timothy J. Scannell and Wendy E. Lane to the Company's Board of Directors (the “Board”), effective immediately. Following these appointments, the Board will consist of eight directors. Quentin Koffey, Lead Independent Director of Masimo, stated, “We are pleased to welcome Tim and Wendy as our newest independent directors. Both are high-caliber professionals.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
As of Oct. 10, 2024, two stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Masimo said on Wednesday that Joe Kiani has decided to resign as CEO, days after shareholders voted to remove him from the company's board.
Masimo (MASI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Activist investor Politan won the two board seats it was seeking at Masimo, defeating founder Joe Kiani and another director at the shareholder vote. Politan nominees Darlene Solomon and Bill Jellison will join two others who were added to the board in a prior proxy fight.
What type of business is Masimo?
Masimo Corporation develops, manufactures, and sells various non-invasive patient monitoring technologies, including monitors or circuit boards, sensors, solutions for remote alarm/monitoring, and software. The basis for the offered solutions and products is the unique patented technologies Masimo SET and rainbow. These technologies are included in various product platforms: pulse oximetry; monitoring of blood components, brain electrical function, acoustic respiration, exhaled gas; bedside and portable monitors; remote patient monitoring systems; integrated display of data and real-time alarm signals, etc. Masimo Corporation was founded in 1989, headquartered in Irvine, California.
What sector is Masimo in?
Masimo is in the Healthcare sector
What industry is Masimo in?
Masimo is in the Medical Devices industry
What country is Masimo from?
Masimo is headquartered in United States
When did Masimo go public?
Masimo initial public offering (IPO) was on 08 August 2007
What is Masimo website?
https://www.masimo.com
Is Masimo in the S&P 500?
No, Masimo is not included in the S&P 500 index
Is Masimo in the NASDAQ 100?
No, Masimo is not included in the NASDAQ 100 index
Is Masimo in the Dow Jones?
No, Masimo is not included in the Dow Jones index
When was Masimo the previous earnings report?
No data
When does Masimo earnings report?
The next expected earnings date for Masimo is 27 February 2025